• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然杀伤细胞调节体内对 SARS-CoV-2 复制的控制和肺损伤的抑制。

NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.

机构信息

Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Duke University School of Medicine, Durham, North Carolina, United States of America.

Department of Infectious Diseases and Global Health, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, United States of America.

出版信息

PLoS Pathog. 2024 Aug 12;20(8):e1012439. doi: 10.1371/journal.ppat.1012439. eCollection 2024 Aug.

DOI:10.1371/journal.ppat.1012439
PMID:39133756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11341101/
Abstract

Natural killer (NK) cells play a critical role in virus control. However, it has remained largely unclear whether NK cell mobilization in SARS-CoV-2 infections is beneficial or pathologic. To address this deficit, we employed a validated experimental NK cell depletion non-human primate (NHP) model with SARS-CoV-2 Delta variant B.1.617.2 challenge. Viral loads (VL), NK cell numbers, activation, proliferation, and functional measures were evaluated in blood and tissues. In non-depleted (control) animals, infection rapidly induced NK cell expansion, activation, and increased tissue trafficking associated with VL. Strikingly, we report that experimental NK cell depletion leads to higher VL, longer duration of viral shedding, significantly increased levels of pro-inflammatory cytokines in the lungs, and overt lung damage. Overall, we find the first significant and conclusive evidence for NK cell-mediated control of SARS-CoV-2 virus replication and disease pathology. These data indicate that adjunct therapies for infection could largely benefit from NK cell-targeted approaches.

摘要

自然杀伤 (NK) 细胞在病毒控制中发挥着关键作用。然而,NK 细胞在 SARS-CoV-2 感染中的动员是有益还是病理性的,在很大程度上仍不清楚。为了解决这一不足,我们采用了经过验证的实验性 NK 细胞耗竭非人类灵长类动物 (NHP) 模型,并用 SARS-CoV-2 Delta 变体 B.1.617.2 进行了挑战。在血液和组织中评估了病毒载量 (VL)、NK 细胞数量、激活、增殖和功能指标。在未耗竭(对照)动物中,感染迅速诱导 NK 细胞扩增、激活,并增加与 VL 相关的组织迁移。引人注目的是,我们报告说,实验性 NK 细胞耗竭导致更高的 VL、更长时间的病毒脱落、肺部促炎细胞因子水平显著增加以及明显的肺部损伤。总的来说,我们发现了 NK 细胞介导的 SARS-CoV-2 病毒复制和疾病病理学控制的第一个重要和明确的证据。这些数据表明,感染的辅助治疗可能会从 NK 细胞靶向治疗中受益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/b6c35dfec0d3/ppat.1012439.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/f327c4dde5a7/ppat.1012439.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/c243cc30d188/ppat.1012439.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/8ea18454594d/ppat.1012439.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/2b8f2c2a13f1/ppat.1012439.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/b6c35dfec0d3/ppat.1012439.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/f327c4dde5a7/ppat.1012439.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/c243cc30d188/ppat.1012439.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/8ea18454594d/ppat.1012439.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/2b8f2c2a13f1/ppat.1012439.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2cb/11341101/b6c35dfec0d3/ppat.1012439.g005.jpg

相似文献

1
NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.自然杀伤细胞调节体内对 SARS-CoV-2 复制的控制和肺损伤的抑制。
PLoS Pathog. 2024 Aug 12;20(8):e1012439. doi: 10.1371/journal.ppat.1012439. eCollection 2024 Aug.
2
Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques.感染 SARS-CoV-2 的老年中国恒河猴中延迟的严重细胞因子风暴和免疫细胞浸润。
Zool Res. 2020 Sep 18;41(5):503-516. doi: 10.24272/j.issn.2095-8137.2020.202.
3
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.SARS-CoV-2 感染可使恒河猴免受再次感染。
Science. 2020 Aug 14;369(6505):812-817. doi: 10.1126/science.abc4776. Epub 2020 May 20.
4
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.SARS-CoV-2 刺突蛋白通过 HLA-E/NKG2A 通路控制自然杀伤细胞的激活。
Cells. 2020 Aug 26;9(9):1975. doi: 10.3390/cells9091975.
5
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.评估 mRNA-1273 疫苗对 SARS-CoV-2 在非人类灵长类动物中的效果。
N Engl J Med. 2020 Oct 15;383(16):1544-1555. doi: 10.1056/NEJMoa2024671. Epub 2020 Jul 28.
6
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.用基于自然杀伤细胞的免疫疗法来平缓 COVID-19 曲线。
Front Immunol. 2020 Jun 23;11:1512. doi: 10.3389/fimmu.2020.01512. eCollection 2020.
7
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.恒河猴初次接触 SARS-CoV-2 可预防再次感染。
Science. 2020 Aug 14;369(6505):818-823. doi: 10.1126/science.abc5343. Epub 2020 Jul 2.
8
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.SARS-CoV-2 和 SARS-CoV 在人肺中的比较复制和免疫激活特征:一项具有 COVID-19 发病机制意义的离体研究。
Clin Infect Dis. 2020 Sep 12;71(6):1400-1409. doi: 10.1093/cid/ciaa410.
9
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.ChAdOx1 nCoV-19 疫苗可预防恒河猴的 SARS-CoV-2 肺炎。
Nature. 2020 Oct;586(7830):578-582. doi: 10.1038/s41586-020-2608-y. Epub 2020 Jul 30.
10
The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.新型冠状病毒 SARS-CoV-2 对自然杀伤细胞的潜在影响;潜在治疗干预的视角。
Front Immunol. 2020 Jul 10;11:1692. doi: 10.3389/fimmu.2020.01692. eCollection 2020.

引用本文的文献

1
An Autoimmunity-associated allele of enhances the innate immune response to promote protection against acute coronavirus infection.一种与自身免疫相关的等位基因增强先天性免疫反应,以促进对急性冠状病毒感染的防护。
bioRxiv. 2025 Jul 18:2025.07.15.664967. doi: 10.1101/2025.07.15.664967.
2
Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness.新型冠状病毒(SARS-CoV-2)中的新出现突变有助于逃避自然杀伤细胞(NK细胞)的识别,并与病毒适应性增强相关。
PLoS Pathog. 2024 Dec 9;20(12):e1012755. doi: 10.1371/journal.ppat.1012755. eCollection 2024 Dec.

本文引用的文献

1
Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells.在 Calu-3 细胞中,感染动力学、合胞体形成和炎症生物标志物可作为 SARS-CoV-2 关注变体致病性的预测指标。
PLoS One. 2024 Apr 3;19(4):e0301330. doi: 10.1371/journal.pone.0301330. eCollection 2024.
2
SARS-CoV-2 immunity in animal models.动物模型中的 SARS-CoV-2 免疫。
Cell Mol Immunol. 2024 Feb;21(2):119-133. doi: 10.1038/s41423-023-01122-w. Epub 2024 Jan 18.
3
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
编码保守非刺突抗原的 T 细胞定向疫苗 BNT162b4 可保护动物免受严重的 SARS-CoV-2 感染。
Cell. 2023 May 25;186(11):2392-2409.e21. doi: 10.1016/j.cell.2023.04.007. Epub 2023 Apr 13.
4
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.Siglec-9 抑制针对 SARS-CoV-2 的抗体依赖的自然杀伤细胞细胞毒性。
mBio. 2023 Feb 28;14(1):e0339322. doi: 10.1128/mbio.03393-22. Epub 2023 Feb 2.
5
Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events.自然杀伤细胞调节急性 SIV 复制、传播和炎症,但不影响独立的传播事件。
J Virol. 2023 Jan 31;97(1):e0151922. doi: 10.1128/jvi.01519-22. Epub 2022 Dec 13.
6
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine.纳米颗粒疫苗诱导的 SARS-CoV-2 中和与保护的广谱性。
Nat Commun. 2022 Oct 23;13(1):6309. doi: 10.1038/s41467-022-33985-4.
7
Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage.SARS-CoV-2 感染食蟹猴早期的蛋白质组学和代谢组学特征
Front Immunol. 2022 Jul 12;13:954121. doi: 10.3389/fimmu.2022.954121. eCollection 2022.
8
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.SARS-CoV-2 感染可导致小鼠肺部上皮细胞和免疫细胞长期功能障碍,并伴有纤维化。
Sci Transl Med. 2022 Sep 28;14(664):eabo5070. doi: 10.1126/scitranslmed.abo5070.
9
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.自然杀伤细胞在 SARS-CoV-2 感染中的作用:病理生理学及治疗意义。
Front Immunol. 2022 Jun 30;13:888248. doi: 10.3389/fimmu.2022.888248. eCollection 2022.
10
All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity.自然杀伤细胞介导的死亡全剧分两幕及意外加演:适应性免疫的启动、执行与激活
Front Immunol. 2022 May 16;13:896228. doi: 10.3389/fimmu.2022.896228. eCollection 2022.